Bupropion as a modulator of drug activity
AssigneeAntecip Bioventures II LLC
InventorHerriot Tabuteau
Life of this patent
Estimating the term…
Abstract
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Claims20
A method of treating nicotine addiction associated with smoking tobacco comprising administering a combination of a therapeutically effective amount of bupropion, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of dextromethorphan, or a pharmaceutically acceptable salt thereof, daily for at least 21 consecutive days to a person suffering from nicotine addiction, wherein the person is an ad-lib tobacco smoker, wherein the combination is in a single dosage form and there are no other therapeutically active agents in the dosage form, wherein the dosage form is administered to the person once daily for three days, followed by twice daily, and wherein the method is more effective than administering the same amount of bupropion, or a pharmaceutically acceptable salt thereof, alone.
A method of treating nicotine addiction associated with smoking tobacco comprising administering a combination of about 105 mg bupropion hydrochloride and about 45 mg dextromethorphan hydrobromide daily for at least 21 consecutive days to a person suffering from nicotine addiction, wherein the person is an ad lib tobacco smoker, wherein the combination is in a single dosage form and there are no other therapeutically active agents in the dosage form, wherein the dosage form is administered to the person once daily for three days, followed by twice daily, and wherein the method is more effective than administering the same amount of the bupropion alone.
Dependencies are inferred from the claim text.